Abstract 2 Development of CAR-NK Cell Therapy for Hematologic Malignancies

INTRODUCTION: Natural killer (NK) cells can kill tumor cells without priming or prior activation through their complement of activating and inhibitory surface molecules. Chimeric antigen receptor (CAR) expression by engineered NK cells can improve both specificity and potency of the NK cells’ anti-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoltzman, Carrie, Chandrasekaran, Devikha, von Euw, Erika, McKay, Cyd, Root, Christina, Delaney, Colleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Preclinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446909/
http://dx.doi.org/10.1093/stcltm/szac057.002

Ejemplares similares

Ejemplares similares